Adaptogenics Health names Antoun Nabhan president to build peptide pipeline
The Vancouver nutraceutical company, known for functional mushroom tinctures, wants a portfolio spanning metabolic health, muscle preservation and inflammation.
TR
By Tom Reyes · Markets Editor
Oct 14 04:39 ETSource: Kalkine Media
The wire
- 01Adaptogenics Health Corp. (CSE:ADPT) said Nabhan became president effective the start of October, charged with identifying and negotiating asset acquisitions, licensing deals and collaborations in peptide and small-molecule therapeutics.
- 02The company currently sells supplements, so any peptide therapeutics effort would be a step into drug development regulation, capital needs and scientific risk.
- 03Nabhan's background is healthcare dealmaking, including roles at Oaktree Capital, Establishment Labs and Pear Therapeutics; no specific peptide assets or programs have been disclosed.
From the source
Read at kalkinemedia.comCan a Veteran Dealmaker Steer Adaptogenics Health Corp. (CSE:ADPT) Into Peptide Therapeutics?
Canadian Utilities Limited (TSX:CU) Breaks Ground on Yellowhead Natura...
